Showing 1 posts of 1 posts found.
The pharma industry has excessive power over EU decision-makers and spends €40 million a year to influence EU drug policy, …
MHRA approves first lower-carbon beclometasone inhalers for asthma
Samsung Biologics launches bid to acquire peptide CDMO PolyPeptide
Novogenia breaks ground on personalised healthcare campus
InfectoPharm launches Polish operations with first hospital antibiotic
FibroFind appoints Lee Borthwick as CEO